New Horizon Health Ltd
HKEX:6606
Relative Value
There is not enough data to reliably calculate the relative value of New Horizon Health Ltd.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
New Horizon Health Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
New Horizon Health Ltd
HKEX:6606
|
6.5B HKD | 4.2 | 52 | -41.3 | -41.3 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.7B USD | 0.3 | 212.6 | 14 | 14 | |
| US |
|
Cigna Corp
NYSE:CI
|
78.2B USD | 0.3 | 12.7 | 0 | 0 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
63.5B EUR | 0.3 | 12.2 | 7.8 | 9.9 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
27.9B EUR | 1.2 | 24.3 | 10.6 | 16.2 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.9B EUR | 1.2 | 33.1 | 10.4 | 22.3 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23B USD | 1.7 | 26.9 | 14.4 | 20.2 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.3B USD | 2 | 22.4 | 12.2 | 16.5 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.8B EUR | 0.6 | 16.2 | 6.4 | 13.7 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.6B USD | 14.1 | -31.8 | -33.6 | -30.5 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10B USD | 0.7 | 12.9 | 7.3 | 10 |